首页> 外文OA文献 >Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.
【2h】

Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.

机译:肝细胞核因子1和C / EBP对人类载脂蛋白B基因第二内含子增强子的活性至关重要。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The tissue-specific transcriptional enhancer of the human apolipoprotein B gene contains multiple protein-binding sites spanning 718 bp. Most of the enhancer activity is found in a 443-bp fragment (+621 to +1064) that is located entirely within the second intron of the gene. Within this fragment, a 147-bp region (+806 to +952) containing a single 97-bp DNase I footprint exhibits significant enhancer activity. We now report that this footprint contains four distinct protein-binding sites that have the potential to bind nine distinct liver nuclear proteins. One of these proteins was identified as hepatocyte nuclear factor 1 (HNF-1), which binds with relatively low affinity to the 5' half of a 20-bp palindrome located at the 5' end of the large footprint. A binding site for C/EBP (or one of the related proteins that recognize similar sequences) was identified in the center of the 97-bp footprint. This binding site is coincident or overlaps with the binding sites for five other proteins, two of which appear to be distinct from the C/EBP-related family of proteins. The binding site for a nuclear factor designated protein I is located between the HNF-1 and C/EBP binding sites. Finally, the 3'-most 15 bp of the footprinted sequence contain a binding site for another nuclear protein, which we have called protein II. Mutations that abolish the binding of either HNF-1, protein II, or the C/EBP-related proteins severely reduce enhancer activity. However, deletion experiments demonstrated that neither the HNF-1-binding site alone, nor the combination of binding sites for HNF-1, protein I, and C/EBP, nor the C/EBP-binding site plus the protein II-binding site is sufficient to enhance transcription from a strong apolipoprotein B promoter. Rather, HNF-1 and C/EBP act synergistically with protein II to enhance transcription of the apolipoprotein B gene.
机译:人载脂蛋白B基因的组织特异性转录增强子包含多个跨越718 bp的蛋白结合位点。大多数增强子活性都位于一个443 bp的片段(+621至+1064)中,该片段完全位于该基因的第二个内含子内。在该片段内,包含单个97-bp DNase I足迹的147-bp区域(+806至+952)表现出显着的增强子活性。现在,我们报告此足迹包含四个不同的蛋白质结合位点,这些位点有可能结合九个不同的肝脏核蛋白。这些蛋白质之一被鉴定为肝细胞核因子1(HNF-1),它以相对较低的亲和力与位于大足迹5'端的20 bp回文的5'一半结合。 C / EBP(或识别相似序列的相关蛋白质之一)的结合位点在97 bp足迹的中心被确定。此结合位点与其他五个蛋白质的结合位点重合或重叠,其中两个似乎与C / EBP相关蛋白家族不同。称为蛋白质I的核因子的结合位点位于HNF-1和C / EBP结合位点之间。最后,足迹序列的3'-最近15 bp包含另一个核蛋白(我们称为蛋白II)的结合位点。消除HNF-1,蛋白II或C / EBP相关蛋白结合的突变会严重降低增强子活性。但是,删除实验表明,既不是单独的HNF-1结合位点,也不是HNF-1,蛋白I和C / EBP结合位点的组合,也不是C / EBP结合位点加上蛋白II结合位点足以增强来自强载脂蛋白B启动子的转录。相反,HNF-1和C / EBP与蛋白II协同作用,以增强载脂蛋白B基因的转录。

著录项

  • 作者

    Brooks, A R; Levy-Wilson, B;

  • 作者单位
  • 年度 1992
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号